Unexpectedly High Efficacy of SARS-CoV-2 BNT162b2 Vaccine in Liver versus Kidney Transplant Recipients—Is It Related to Immunosuppression Only?

The BNT162b2 vaccine is reportedly effective in preventing severe disease in more than 90% of the general population, but its efficacy in transplant recipients remains controversial. We aimed to determine the immune response to the BNT162b2 vaccine in kidney (KTRs) and liver transplant recipients (L...

Descripción completa

Detalles Bibliográficos
Autores principales: Nazaruk, Paulina, Monticolo, Marta, Jędrzejczak, Anna Maria, Krata, Natalia, Moszczuk, Barbara, Sańko-Resmer, Joanna, Pilecki, Tomasz, Urbanowicz, Arkadiusz, Florczak, Michał, Pączek, Leszek, Foroncewicz, Bartosz, Mucha, Krzysztof
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703477/
https://www.ncbi.nlm.nih.gov/pubmed/34960200
http://dx.doi.org/10.3390/vaccines9121454

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8703477/
https://www.ncbi.nlm.nih.gov/pubmed/34960200
http://dx.doi.org/10.3390/vaccines9121454

Ejemplares similares